{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:18:22Z","timestamp":1761675502762},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ejim.2006.10.008","type":"journal-article","created":{"date-parts":[[2007,7,14]],"date-time":"2007-07-14T12:40:02Z","timestamp":1184416802000},"page":"417-422","source":"Crossref","is-referenced-by-count":21,"title":["Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature"],"prefix":"10.1016","volume":"18","author":[{"given":"Luigi","family":"Cavanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Bert\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Arcari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Mordenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Vallisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2006.10.008_bib1","first-page":"3383","article-title":"Efficacy of pamidronate in breast cancer with bone metastases: a randomised, double-blind placebo-controlled multicenter study","volume":"19","author":"Hultborn","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejim.2006.10.008_bib2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomised, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2006.10.008_bib3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomised, double-blind, multicenter, comparative trial","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2006.10.008_bib4","first-page":"879\u20132","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejim.2006.10.008_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejim.2006.10.008_bib6","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2006.10.008_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejim.2006.10.008_bib8","first-page":"750S","article-title":"Osteonecrosis of the maxilla and mandible in patients treated with bisphosohonates: a retrospective study [abstract]","volume":"23","author":"Estillo","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2006.10.008_bib9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ejim.2006.10.008_bib10","doi-asserted-by":"crossref","first-page":"216A","DOI":"10.1182\/blood.V104.11.756.756","article-title":"Osteonecrosis of the jaws in myeloma: time dependent correlation with Aredia and Zometa use [abstract]","volume":"104","author":"Durie","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2006.10.008_bib11","doi-asserted-by":"crossref","first-page":"313B","DOI":"10.1182\/blood.V104.11.4925.4925","article-title":"Bisphosphonate therapy associated with an increased incidence of mandibular\/maxillary osteomyelitis in multiple myeloma patients [abstract]","volume":"104","author":"Thakkar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2006.10.008_bib12","doi-asserted-by":"crossref","first-page":"308B","DOI":"10.1182\/blood.V104.11.4905.4905","article-title":"Oral cavity avascular bone necrosis: a newly recognized complication of intravenous (IV) bisphosphonate therapy in cancer patients [abstract]","volume":"104","author":"Schuster","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2006.10.008_bib13","doi-asserted-by":"crossref","first-page":"315B","DOI":"10.1182\/blood.V104.11.4933.4933","article-title":"Osteonecrosis of the jaw in myeloma patients receiving pamidronate and zoledronate [abstract]","volume":"104","author":"Kut","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2006.10.008_bib14","first-page":"131S","article-title":"Osteonecrosis of the jaw in patients with metastatic breast cancer [abstract]","volume":"88","author":"Van Poznak","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejim.2006.10.008_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.2005.tb06761.x","article-title":"Bisphosphonates and vascular necrosis in the jaw: a possible association","volume":"182","author":"Carter","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejim.2006.10.008_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ejim.2006.10.008_bib17","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.ejim.2006.10.008_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejim.2006.10.008_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.20481","article-title":"Osteonecrosis of the jaw associated with pamidronate therapy","volume":"81","author":"Zarychanski","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2006.10.008_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2006.10.008_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emergine oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2006.10.008_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates \u2014 histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ejim.2006.10.008_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JOP.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Prac"},{"key":"10.1016\/j.ejim.2006.10.008_bib24","unstructured":"Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws: June 2004. professional education material: Novartis, June 2004."},{"key":"10.1016\/j.ejim.2006.10.008_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.59.2.193","article-title":"Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the colesterol biosynthesis pathway in keratinocyte model for esophageal irritation","volume":"59","author":"Reszka","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejim.2006.10.008_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/keh481","article-title":"Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the Hip: a prospective open-label study","volume":"44","author":"Agarwala","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2006.10.008_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2141.2005.05833.x","article-title":"Bisphosphonate-associated osteonecrosis of the auditory canal","volume":"132","author":"Polizzotto","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2006.10.008_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0030-4220(93)90433-5","article-title":"Lingual mandibular sequestration and ulceration","volume":"75","author":"Peters","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.ejim.2006.10.008_bib29","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2006.10.008_bib30","series-title":"Presented at the annual meeting of the American Society for clinical oncology","first-page":"799","article-title":"Adverse event (AE) reporting of oral clodronate with emphasis on osteonecrosis of the iaws [abstract]","author":"Jones","year":"2005"},{"issue":"4","key":"10.1016\/j.ejim.2006.10.008_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","article-title":"Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws","volume":"35","author":"Chiandussi","year":"2006","journal-title":"Dentomaxillofac Radiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362050700146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362050700146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:18:29Z","timestamp":1587773909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362050700146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S095362050700146X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2006.10.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}